OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis $2.35 0.00 (0.00%) As of 10/2/2024 Add Compare Share Share Stock Analysis Stock AnalysisEarningsHeadlinesInsider TradesBuy This Stock About Augmedix Stock (OTCMKTS:AUGX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Augmedix alerts:Sign Up Key Stats Today's Range$2.35▼$2.3550-Day Range$2.35▼$2.3552-Week Range$0.73▼$6.25VolumeN/AAverage Volume635,746 shsMarket Capitalization$115.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAugmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Read More… Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Email Address AUGX Stock News HeadlinesLake Street Downgrades Augmedix (AUGX)July 23, 2024 | msn.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Augmedix, Inc. BuyoutJuly 22, 2024 | stockhouse.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. April 26, 2025 | Golden Portfolio (Ad)Augmedix Agrees to $139 Million Acquisition by CommureJuly 19, 2024 | marketwatch.comAUGX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Augmedix, Inc. Is Fair to ShareholdersJuly 19, 2024 | tmcnet.comAI-Focused Healthcare Documentation Provider Augmedix Goes Private In $139M DealJuly 19, 2024 | msn.comAugmedix to be acquired by Commure in transaction valuing the former at ~$139MJuly 19, 2024 | msn.comWhy Is Augmedix, Inc. (AUGX) the Best Penny Stock to Buy Under $1?July 15, 2024 | insidermonkey.comSee More Headlines AUGX Stock Analysis - Frequently Asked Questions How have AUGX shares performed this year? Augmedix's stock was trading at $2.35 at the beginning of 2025. Since then, AUGX stock has increased by 0.0% and is now trading at $2.35. View the best growth stocks for 2025 here. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) issued its earnings results on Monday, March, 27th. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.16) by $0.01. The firm earned $8.75 million during the quarter, compared to the consensus estimate of $8.52 million. Augmedix had a negative net margin of 57.70% and a negative trailing twelve-month return on equity of 980.09%. How do I buy shares of Augmedix? Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Augmedix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include Meta Platforms (META), Urban Outfitters (URBN), Arista Networks (ANET), Capital Southwest (CSWC), NVIDIA (NVDA), PACCAR (PCAR) and Turkcell Iletisim Hizmetleri A.S. (TKC). Company Calendar Last Earnings3/27/2023Today4/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health Information Services Sub-IndustryBusiness Services Current SymbolOTCMKTS:AUGX CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees710Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,450,000.00 Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$51.58 million Price / Sales2.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book23.50Miscellaneous Outstanding Shares48,968,000Free Float36,316,000Market Cap$115.07 million OptionableNot Optionable Beta-0.22 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:AUGX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.